Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
01/2013
01/02/2013CN101277946B Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes
01/02/2013CN101273016B 抗菌喹啉衍生物 Antibacterial quinoline derivatives
01/02/2013CN101087757B Novel dipeptidyl peptidase iv inhibitors, process for their preparation and compositions containing them
01/02/2013CN101084195B 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
01/01/2013US8344138 Triazinedione derivatives as GABAB receptor modulators
01/01/2013US8344010 Fused imidazole derivatives as TRPV3 antagonist
01/01/2013US8344004 Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
01/01/2013US8344003 2-pyridinecarboxamide derivatives
01/01/2013US8343999 Thiazolyl compounds useful as kinase inhibitors
01/01/2013US8343980 Quinazoles useful as modulators of ion channels
01/01/2013US8343970 PDE10 inhibitors and related compositions and methods
01/01/2013US8343913 Hsp90, buffering and drug resistance
12/2012
12/27/2012WO2012178015A2 Lrrk2 inhibitors
12/27/2012WO2012177728A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177725A1 Metalloenzyme inhibitor compounds
12/27/2012WO2012177603A2 Metalloenzyme inhibitor compounds
12/27/2012WO2012176123A1 3 - imidazolyl- indoles for the treatment of proliferative diseases
12/27/2012WO2012176061A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/27/2012WO2012175581A1 Antiviral compounds
12/27/2012WO2012175536A1 Dyes, method of making them, and their use in dye-sensitized solar cells
12/27/2012WO2012175522A1 Polymorphs of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
12/27/2012WO2012071509A3 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
12/27/2012US20120330028 Method for preparing polybiotinylated compounds
12/27/2012US20120330024 Radioactive iodine labeled organic compound or salt thereof
12/27/2012US20120330020 Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
12/27/2012US20120330019 Hepatitis C Virus Inhibitors
12/27/2012US20120330014 Method for producing imatinib base
12/27/2012US20120330009 Triazole compounds that modulate hsp90 activity
12/27/2012US20120329830 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use
12/27/2012US20120329820 Pyridinoylpiperidines As 5-HT1F Agonists
12/27/2012US20120329811 Heteroaromatic Derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
12/27/2012US20120329807 Multimeric VLA-4 Antagonists Comprising Polymers Moieties
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329788 Metalloenzyme inhibitor compounds
12/27/2012US20120329787 Fungicidal pyranones and oxazinones
12/27/2012US20120329786 Compounds and therapeutic uses thereof
12/27/2012US20120329784 Compounds and methods
12/27/2012US20120329778 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/27/2012US20120329775 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
12/27/2012US20120329772 Amino-tetrazoles analogues and methods of use
12/27/2012US20120328691 Anilinopiperazine derivatives and methods of use thereof
12/27/2012US20120328569 Inhibitors of hepatitis c virus ns5b polymerase
12/27/2012US20120328565 Antiviral compounds
12/27/2012CA2839883A1 Metalloenzyme inhibitor compounds
12/27/2012CA2839699A1 Trpm8 antagonists and their use in treatments
12/27/2012CA2839621A1 Polymorphs of (s)-pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol-2-yl}-amide
12/27/2012CA2838916A1 Metalloenzyme inhibitor compounds
12/27/2012CA2838909A1 Metalloenzyme inhibitor compounds
12/27/2012CA2837178A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/26/2012EP2537847A1 Polymorphs of dasatinib and process for preparation thereof
12/26/2012EP2537846A1 Organic compounds
12/26/2012EP2537830A1 Compounds and compositions as protein kinase inhibitors
12/26/2012EP2536717A1 Aminothiazolones as estrogen related receptor-alpha modulators
12/26/2012EP2536716A1 Aminothiazolones as estrogen related receptor-alpha modulators
12/26/2012EP2536715A1 Preparation of lamivudine form i
12/26/2012EP2536711A1 5-ht receptor modulators
12/26/2012EP2536710A2 Piperidine derivatives
12/26/2012EP2536706A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
12/26/2012EP2536285A1 Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
12/26/2012CN1826333B Diamine derivatives
12/26/2012CN1816536B Regulator of cannabinoid receptor
12/26/2012CN102844315A Crystalline salts of a potent hcv inhibitor
12/26/2012CN102838595A Preparation method of high-purity dasatinib and by-product of dasatinib
12/26/2012CN102838594A Preparation and refining methods of dasatinib
12/26/2012CN102838593A 2-(4-methyl-1,2,3-thiadiazole)-5-(substituent)-1,3,4-oxa(thia)diazole derivative and application thereof
12/26/2012CN102838592A 2,4-diaryl thiazole derivative, and pharmaceutical composition, preparation method and application thereof
12/26/2012CN102838539A Quinolinylenamide derivative and its application in preparation of anti-malignant tumor drugs
12/26/2012CN102838532A Novel compounds for a treatment of diseases associated with amyloid or amyloid-like proteins
12/26/2012CN102153502B Carbazole derivative and light-emitting element and light-emitting apparatus using carbazole derivative
12/26/2012CN101838474B Organic dye and preparation method and application thereof
12/26/2012CN101466678B Substituted 3-cyanopyridines as protein kinase inhibitors
12/25/2012US8338615 Human protein tyrosine phosphatase inhibitors and methods of use
12/25/2012US8338608 Inhibitors of ion channels
12/25/2012US8338595 Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
12/25/2012US8338460 2-pyridinecarboxamide derivative having GK-activating effect
12/25/2012US8338440 Inhibitors of IAP
12/25/2012US8338429 2-acylaminothiazole derivative or salt thereof
12/25/2012US8338406 Benzodiazepine compound and pharmaceutical composition
12/25/2012US8338401 Coumarin-amide derivatives and its preparation, said drug composition and its use
12/20/2012WO2012173099A1 Endothelial-lipase-inhibiting amino derivative
12/20/2012WO2012148252A3 Metformin-based ionic co-crystals
12/20/2012WO2012145617A3 Aminopyrimidine kinase inhibitors
12/20/2012US20120323000 Z-selective ring-closing metathesis reactions
12/20/2012US20120322838 Epothilone Compounds, Preparation Method and Use Thereof
12/20/2012US20120322804 N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322787 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/20/2012US20120322785 Substituted 6,6-fused nitrogenous heterocyclic compounds and uses thereof
12/20/2012US20120321622 Compositions of Kinase Inhibitors and Their Use for Treatment of Cancer and Other Diseases Related to Kinases
12/20/2012US20120321590 Bridged polycyclic compounds
12/20/2012US20120321563 Carbonic Anhydrase Targeting Agents and Methods of Using Same
12/20/2012CA2837268A1 Compositions and methods for modulating a kinase
12/19/2012EP2535339A1 Polymorphs of dasatinib, preparation methods and pharmaceutical compositions thereof
12/19/2012EP2535331A1 Condensed-Cyclic Compound and Organic Light-Emitting Diode Comprising the Same
12/19/2012EP2534146A1 Method of making coupled heteroaryl compounds via rearrangement of halogenated heteroaromatics followed by oxidative coupling
12/19/2012EP2534139A1 Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue
12/19/2012EP2533783A1 Compounds and methods
12/19/2012CN102834392A Aminothiazolones as estrogen related receptor-alpha modulators
12/19/2012CN102834382A Pyrazole derivatives as modulators of calcium release-activated calcium channel
12/19/2012CN102834380A Inhibitors of protein kinases
1 ... 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 ... 628